相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。European cancer mortality predictions for the year 2011
M. Malvezzi et al.
ANNALS OF ONCOLOGY (2011)
Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: A meta-analysis
Chang-Peng Zhu et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Pancreatic Cancer
Manuel Hidalgo
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Long-Term Outcome of Mitomycin C- and 5-FU-Based Primary Radiochemotherapy for Esophageal Cancer
Maria Wolf et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2010)
Volumetric Modulated Arc Therapy for Advanced Pancreatic Cancer
Wietse Eppinga et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2010)
Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
Sonja Gillen et al.
PLOS MEDICINE (2010)
Downstaging of Pancreatic Carcinoma after Neoadjuvant Chemoradiation
Dominik Tinkl et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2009)
Meta-analysis of randomized trials: Evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer
Volker Heinemann et al.
BMC CANCER (2008)
Single-nucleotide polymorphisms of DNA damage response genes are associated with overall survival in patients with pancreatic cancer
Taro Okazaki et al.
CLINICAL CANCER RESEARCH (2008)
Increased survival using platinum analog combined with gemcitabine as compared to single-agent gemcitabine in advanced pancreatic cancer: pooled analysis of two randomized trials, the GERCOR/GISCAD intergroup study and a German multicenter study
V. Heinemann et al.
ANNALS OF ONCOLOGY (2007)
Antimetabolite radiosensitizers
Donna S. Shewach et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: Results of the North Central Cancer Treatment Group Phase II Study N9942
Michael G. Haddock et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies
Florence Huguet et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A randomized Phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern cooperative oncology group study E8282
SJ Cohen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Concurrent chemoradiotherapy with gemcitabine and cisplatin after incomplete (R1) resection of locally advanced pancreatic carcinoma
R Wilkowski et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: Gemcitabine versus 5-fluorouracil, a randomized controlled study
CP Li et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Concurrent chemoradiotherapy with gemcitabine and cisplatin for pancreatic cancer: From the laboratory to the clinic
Z Symon et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?
CH Crane et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)